Precise Therapy for Patients With AML: Experts Discuss Clinical Challenges and Future Directions

In this online program faculty experts explore the latest developments in individualizing therapy for patients with AML through the use of recently approved targeted agents novel immunotherapies and investigational agents. 

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Agios Pharmaceuticals

Boston Biomedical

Celgene TEXT Only

Daiichi Sankyo, Inc.